Clinical Trial Update: Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of AEG33773 versus placebo in patients with painful diabetic peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Pain

Drugs mentioned

• AEG33773

Snippet

Sponsor: Aegera Therapeutics | Conditions: Diabetic Peripheral Neuropathy, Chronic Pain | Phase 2 | Status: COMPLETED